140 related articles for article (PubMed ID: 16456109)
1. Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implications.
Michelakis ED
Circ Res; 2006 Feb; 98(2):172-5. PubMed ID: 16456109
[No Abstract] [Full Text] [Related]
2. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
3. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma?
Stewart DJ
Circ Res; 2005 May; 96(10):1033-5. PubMed ID: 15920025
[No Abstract] [Full Text] [Related]
5. [BMP receptors and signal transduction].
Hayashi M; Imamura T; Miyazono K
Nihon Rinsho; 2005 Oct; 63 Suppl 10():399-403. PubMed ID: 16279670
[No Abstract] [Full Text] [Related]
6. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.
Jurasz P; Courtman D; Babaie S; Stewart DJ
Pharmacol Ther; 2010 Apr; 126(1):1-8. PubMed ID: 20117135
[TBL] [Abstract][Full Text] [Related]
7. Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children.
Hall S; Brogan P; Haworth SG; Klein N
Thorax; 2009 Sep; 64(9):778-83. PubMed ID: 19525266
[TBL] [Abstract][Full Text] [Related]
8. [Primary pulmonary hypertension].
Otsuka F; Makino H
Nihon Rinsho; 2005 Oct; 63 Suppl 10():450-7. PubMed ID: 16279681
[No Abstract] [Full Text] [Related]
9. [Pulmonary arterial hypertension and BMP system abnormality].
Otsuka F
Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
[TBL] [Abstract][Full Text] [Related]
10. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
11. Pathology of pulmonary hypertension.
Tuder RM; Marecki JC; Richter A; Fijalkowska I; Flores S
Clin Chest Med; 2007 Mar; 28(1):23-42, vii. PubMed ID: 17338926
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
Ye L; Kynaston H; Jiang WG
Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II.
Burton VJ; Holmes AM; Ciuclan LI; Robinson A; Roger JS; Jarai G; Pearce AC; Budd DC
Blood; 2011 Oct; 118(17):4750-8. PubMed ID: 21900197
[TBL] [Abstract][Full Text] [Related]
14. Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease.
Lévy M; Maurey C; Celermajer DS; Vouhé PR; Danel C; Bonnet D; Israël-Biet D
J Am Coll Cardiol; 2007 Feb; 49(7):803-10. PubMed ID: 17306711
[TBL] [Abstract][Full Text] [Related]
15. Cellular and molecular pathobiology of pulmonary hypertension conference summary.
Rabinovitch M
Chest; 2005 Dec; 128(6 Suppl):642S-646S. PubMed ID: 16373886
[No Abstract] [Full Text] [Related]
16. Pulmonary arterial hypertension: a look to the future.
Rubin LJ; Galiè N
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):89S-90S. PubMed ID: 15194184
[TBL] [Abstract][Full Text] [Related]
17. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
[TBL] [Abstract][Full Text] [Related]
18. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension.
Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC
Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866
[TBL] [Abstract][Full Text] [Related]
19. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling.
Hartung A; Bitton-Worms K; Rechtman MM; Wenzel V; Boergermann JH; Hassel S; Henis YI; Knaus P
Mol Cell Biol; 2006 Oct; 26(20):7791-805. PubMed ID: 16923969
[TBL] [Abstract][Full Text] [Related]
20. [Apoptotic deregulation of endothelial cells and intimal proliferation in pulmonary hypertension of congenital heart disease].
Lévy M; Raisky O; Vouhé PR; Celermajer DS; Bonnet D; Israël-Biet D
Arch Mal Coeur Vaiss; 2007 May; 100(5):365-72. PubMed ID: 17646759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
